CLINICAL_TRIALS
trial_result
· 2020-04-07
Clinical Trial Update: Study of MK-0663/Etoricoxib in Postorthopedic Knee Replacement Surgery Pain (MK-0663-098) [Phase 3]
Summary
Phase 3 trial of MK-0663/Etoricoxib for postoperative pain after knee replacement completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Organon and Co | Conditions: Pain, Postoperative | Phase 3 | Status: COMPLETED | Results posted: 2020-04-07